Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Arthritis and Rheumatism|September 24, 2010
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responsesJeroen N Stoop, Rachel A Harry, Alexei von Delwig, et al.
Arthritis and Rheumatism|February 1, 2006
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse modelAlexei von Delwig, Daniel M Altmann, John D Isaacs, et al.
Rheumatology (Oxford, England)|March 27, 2012
Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responsesAmy E Anderson, Alice R Lorenzi, Arthur Pratt, et al.
Journal of Autoimmunity|July 9, 2019
Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort studyKenneth F Baker, Andrew J Skelton, Dennis W Lendrem, et al.
Annals of the Rheumatic Diseases|November 23, 2006
T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic miceAlexei von Delwig, Daniel M Altmann, Fraser G Charlton, et al.
Rheumatology (Oxford, England)|March 10, 2009
A novel paradigm for dendritic cells as effectors of cartilage destructionRachel L Lakey, Tanya G Morgan, Andrew D Rowan, et al.
Pharmaceutical Statistics|November 13, 2015
Teaching examples for the design of experiments: geographical sensitivity and the self-fulfilling prophecyDennis W Lendrem, B Clare Lendrem, Ruth Rowland-Jones, et al.
Rheumatology Advances in Practice|August 22, 2019
Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label studyJohn D Isaacs, Abdelrazig Salih, Thomas Sheeran, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Pageof 21